Reuters logo
in 4 months
BRIEF-Nabriva Therapeutics provides business and development update and reports 2016 financial results
March 24, 2017 / 8:10 PM / in 4 months

BRIEF-Nabriva Therapeutics provides business and development update and reports 2016 financial results

1 Min Read

March 24 (Reuters) - Nabriva Therapeutics AG

* Nabriva Therapeutics provides business and development update and reports 2016 financial results

* Nabriva Therapeutics AG- Expect to complete patient enrollment for leap 2 in Q4 of 2017

* Nabriva Therapeutics AG- Anticipate receiving top-line data for leap 2 in Q1 of 2018

* Nabriva Therapeutics AG - Expect year-end balance will be sufficient to fund our operating expenses and capital expenditures at least into Q2 of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below